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Abstract 
Background: Infantile hemangiomas are alarming to new parents and it is natural that their concerns 
are brought to the medical clinician.  Educating the parents about the tumors and the anticipated 
growth process of the tumor is crucial.  This educational opportunity needs to be covered prior to 
discussion treatment options.  The treatment options are complex, for hemangiomas, but the focus of 
this article contrasts laser therapy and the no treatment option.   
Methods: This article is a systematic review designed to examine the literature available and to 
determine if laser therapy is an effective treatment for infantile hemangiomas.   
Hypothesis:  Laser therapy has a greater number of positive treatment outcomes compared to no 
treatment. 
Results: Six studies were reviewed on hemangioma therapy using a laser.  Laser therapy was found to 
be helpful in reducing redness and surface area of superficial hemangiomas on all skin types.   
Conclusion: If laser therapy is going to be used is should be started early in the hemangiomas 
appearance. Watchful waiting is usually the default option because the parents are not trained to 
recognize the hemangioma formation early in the growth staging.  Laser therapy is most effective for 
superficial hemangiomas. 
Keywords: Hemangioma, haemangioma, infancy, complications, skin, vascular malformations, 
angiogenesis, and markers, pulse dye laser, long-pulsed dye laser, laser. 
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Effectiveness of Pulse Dye Laser in the Treatment of Infantile Hemangiomas. 
Introduction  
 Vascular abnormalities are the most common neoplasm in the neonatal population.  These 
tissue developments are seen in up to 12% of children in the first year of their lives. 1 The management 
of vascular developments is burdened by inconsistent nomenclature.  Several types of classification 
systems have attempted to label vascular developments as biologic in nature, clinical, anatomic, 
pathologic, embryologic, or by the use of a general physical description. 2-4 
 During the mid-nineteenth century histopathologic identification was based on size of the 
vessels.  This type of systemized categorization, developed by Virchow, included angioma simplex, 
angioma cavernosum, and angioma racmosum.3  Additional classifications, based on pathologic, 
embryologic and lymphatic lesion were attempted but they were not successful. 3 Edgerton, 1976, 
started the clinical classification of angiomas according to their history.  He divided angiomas into the 
following categories: those that may be expected to resolve spontaneously, those that grow into 
adjacent structures, and those that did not change if left untreated.  Although, the classification system 
could recognize the possibilities, no true biological identification system existed until 1982. 2  
Mulliken and Glowacki defined the difference between vascular abnormalities as either, a 
hemangioma, or a malformation.  These identifications were made based on clinical, and then 
histological findings.  Today, both radiographic and biochemical approaches have supported their 
classifications as valid. 5 
 Hemangiomas are lesions that are composed of excessive endothelial cell turnover.  Most often 
these tumors are discovered visually during the first year of life and they start to grow quickly.  During 
the next several years until the tissue involutes. 4 
 Females have a greater occurrence of hemangiomas than males.  With a 2-5 times higher rate. 6-
8  The ratio is much more equal with congenital hemangiomas, vascular malformations, and 
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kaposiform hemangioendotheliomas in regards to gender. 2, 8, 9, 10  The greatest number of 
hemangiomas are located in the cervicofacial area, 60%. (16)  Up to 80% of the affected children have 
only one lesion, while the other 20% have more than one lesion. 6   
 The occurrence of hemangiomas is random, and studies on dizygotic and monozygotic twins 
did not determine a genetic association. 7 There have been reports of familial hemangiomas with a 
possible inheritance link. 11 
 Hemangiomas can be visceral, deep, or superficial in development.  Superficial tumors are 
often crimson in color and can be referred to as strawberry hemangiomas.  Tissue that is pale, purple, 
or blue is often confused with venous malformations. 12  
 Appearance of the hemangiomas generally occurs in the second month of life.  The tissue can 
be erythematous or telangiectasia, with a circumscribed faded ring.  The expansive growth is present 
between 4 and 8 months after which the tissue stabilizes in size.  Involution of the tumor can start 
around 12 months old and be identified by changes in color.  As the color fades and the turgidity of the 
tissue can develop.  Proliferation and involution of the hemangioma can occur simultaneously. The 
involution process can continue for up to 12 years of the child’s life. 3, 6 Fifty percent of the 
hemangiomas involute by 5 years; of the remaining 50%, 70% will be gone by age seven; usually the 
remainder will resolve gradual before age 12.  The rate of involution does not seem to be influenced by 
the location of the hemangioma.  There is no correlation between size, gender, ulceration, depth, and 
presentation and rate of resolution. An early involution is associated with an optimum outcome.  After 
involution of the tumor occurs, loose skin or scarring may remain. 6   
 Growth staging was identified in one study: ‘Growth characteristics of Infantile Hemangiomas: 
Implications for Management’, “based on global assessment that includes parental history, assessment 
of interval growth, and investigator assessment as follows: Nascent, referring to a premonitory mark; 
early proliferative, denoting the rapid proliferative phase late proliferative, reflecting, ongoing albeit 
less rapid growth; plateau phase, involution and abortive.” 13 This study gauged development in an 
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objective form.  Based on this criterion, the patient was referred to a specialist, 76% of the time, with 
an average of 5 months since the initial discovery by the parent. 13 
 Hemangiomas have a 2 month onset, are raised, and are benign.  Diagnosis is often made by the 
history, biopsy, and imaging, including the use of doppler ultrasound.   Doppler ultrasound, which is 
cost effective, and carries the lowest long-term threat to the infant’s health, is preferred. 2  
 Vascular malformations are the result of misguided morphogenesis that is divided into 
subcategories that include: combined forms, lymphatic, arterial, venous, and capillary.  The combined 
forms occur widely.  Low fluid flowing tumors include venous malformations, lymphatic, and 
capillary tumors. High fluid flowing tumors are associated with arteriovenous fistulas and 
arteriovenous malformations.  These endothelium malformations are not hyperplastic and their cellular 
turnover rate is normal.  The clinician will not be able to empty the blood supply with touch pressure.  
The tumors are not susceptible to antiproliferative treatments like chemotherapy, radiation, or 
antiangiogenic agents like interferon and corticosteroids. 14, 15, 16  Female infants are affected by these 
tumors as often as male infants.  The lesions are present at birth but may remain undetected until 
puberty.  Vascular malformations are susceptible to the hormonal changes of pregnancy.  Trauma or 
infection of the tissue could result in a period of rapid development.  The most notable differences 
between hemangiomas and vascular malformations, is that malformation do not involute over time. 3, 5 
 Imaging such as magnetic resonance imaging, computerized tomography, and arteriography 
show that hemangiomas are highly distinguishable from other tumors.  In 93% of cases, imaging was 
effective in defining: abnormal structures, assess treatment options, planning a surgery, and 
eliminating the concern for visceral attachment. 12, 14-18   In the two studies between computer 
tomography and magnetic resonance imaging the finding are similar. 15 A study supporting computer 
tomography in hemangioma identification is ‘The Value of Three-Dimensional Computer 
Tomographic Angiography in the Diagnosis and Treatment of Vascular Lesions’.  This study 
demonstrated the flaws in doppler ultrasound’s ability to distinguish lesions from surrounding 
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structures.  The study in 2006-2007 used 16 patients with ages ranging from 75 days to 55 years of 
age, the average age being 11.3 years.  The study found that intervention is based on the diagnosis and 
that accuracy could come from computer tomography.  It should be noted, that the imaging is 
expensive and there is a great deal of concern about radiation exposure in children. 19 
 Treatment specific to this article include laser therapy.  The laser uses light frequencies to enter 
the tissue of the tumor and coagulate the vessel in the tumor.  The goal of laser therapy is to destroy the 
tumor tissue without harming the surrounding tissue.  This procedure should cause the tumor tissue to 
involute more quickly. 19, 20 
 The flashlamp-pumped dye laser (FPDL) operates by selective photothermolysis.  The energy 
emitted is selectively absorbed by the red blood cells in the form of heat. Coagulation occurs from 
thermal damage to the vessel. Heat is not transferred to adjacent dermal tissue because the laser energy 
is delivered in a pulse that lasts 450 microseconds. The rapid delivery rate of the FPDL ensures a low 
risk of scarring. The FPDL penetrates the first 1mm of the skin. This explains why superficial 
hemangiomas are more affected than mixed or deep hemangiomas. 21 
 The FPDL delivers the energy beam through a thin fiber optic line connected to a hand-piece. 
The hand-piece contains an aiming beam and laser beam. The hand-piece is held perpendicular to the 
treatment site, with its stem adjacent to the aiming beam resting directly upon the skin. 21 
 With this background a focus on the systematic treatment of pulse dye laser treatments versus 
no treatment for the infantile hemangiomas (IH) should become more understandable. 
Review Design 
 An exhaustive search of available medical literature with an approach to understanding the 
subject was completed.  Studies pertaining to specific findings were included but limited to studies that 
were available for analysis on the subject of laser therapy for infantile hemangiomas.  This type of 
research did not have a need to eliminate patient bias as the patients were infants who could not mask 
physical changes during the treatment phase.   
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Purpose of study 
 This systematic review was done to evaluate the effectiveness of pulse dye laser versus no 
treatment in the treatment of infantile hemangiomas.  There have been advances in the laser treatments 
during the last 50 years and evaluation of the progress, based on the available studies and research 
needed to be completed.  In order to select a laser treatment the ratio of the most benefit verses the 
lowest complications needed to be discovered. 22   
Significance 
 Hemangioma lesions are one of the most common findings in infants.  There is a correlation 
with well child visits which focuses the cosmetic concern raised by the parents.  Due to the appearance 
of the tumor the parents seek specific guidance to resolve their concerns.  These benign tumors effect 
the families’ social environment because they often grow on the child’s face. 22 In order to recommend 
a treatment that does not involve systemic medication or surgery the strengths and weakness of laser 
therapy would need to be explored.  Selecting a treatment that is mildly painful, laser therapy, for a 
tumor that would most likely diminish in time becomes increasing challenging.  This is why a study to 
measure which type of laser treatment would bring the most benefit was completed. 20 
Methods and Materials                                       
 An extensive literature search was conducted, using the following search engines: Medline-
Ovid, MD Consult, and CINAHL. Inclusion criteria: English, published since 1990, individuals with 
hemangiomas (or haemangiomas British English), various Fitzpatrick skin phototypes that included 
fair skin to dark skin, and laser treatment.  The inclusion criterion for this study was: randomized 
studies, non-randomized, and infants.  The exclusion criterion was applied to meta-analysis, steroids, 
life threatening, and articles published prior to 1990. All trials with a JADAD score of 2 or higher were 
used for this review due to the limited number of studies on various lasers. Systematic reviews 
included information from professional journals and the makers of the laser products.  Articles from 
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1974-2007 were used to support the introduction and articles from 1990-2007 were used to evaluate 
laser therapy. 
Results 
 In 1995 Levine, et al, discussed the possibilities of traditional pulse dye laser (TPDL) for 
reducing the symptoms of hemangiomas. The study continued to relate her findings to a series of 
experiments on 25 IH.  Of the 25 patients, with IH, that were treated with TPDL 16% atrophied, 21% 
showed hyperpigmentation, and 10% showed hypopigmentation.  Scarring was not appreciated on any 
of the patients.  The laser was made by the Candela Corp of Wayland, MA and after 1988 the 
wavelength was tuned to 585nm which was 8nm of an increase.  This higher energy level was 
specified for the depth of the IH.  The patients were treated every 2-8 weeks until the results were 
favorable. 23   
 The additional study included 43 cases where IH were treated among 500 patients.  The 
remaining patients had other skin disorders that were being treated with TPDL and the results were 
grouped in a manner to include all the adverse reactions together.  It is not known how the 43 patients 
who received TPDL reacted but the author closes with a statement referring to the safety of the 
TPDL.23 
 In Berlin, Germany a study by Poetke, et al, was conducted in 1996-1998, and published in 
2000.  It included 165 patients with 225 IH with a mean follow up of 5 months. The average age of the 
patient was 14 weeks old.  The patients were divided into 3 groups.  Group one contained 47 patients 
with 54 combined subcutaneous and deep tumors.  The second group contained 100 patients with 
superficial hemangiomas.  The third group contained 18 patients with 18 superficial hemangiomas that 
were in the involution stage. Of the 165 patients 85 had IH on the face or neck. Treatment with the 
TPDL was conducted approximately every 4 weeks until the results were achieved.  Of the 165 
patients 30 underwent general anesthesia because of the proximity to the eye. 24  
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 The laser was used for 1-10 millionth of a second with a thermal relaxation time (TRT) of less 
time than the laser blast. After the laser treatment the patient’s IH was dressed with panthenol ointment 
and a parent cleaned the area with providone-iodine at home.  The patient was to have groomed nails 
or gloves on during the recovery period.  This precaution was intended to reduce any physical trauma 
to the treated IH.  24 
 A rating of excellent was in correlation to a total reduction of the IH to a state consistent with 
the surrounding tissue.  The rating of good was awarded if the lesion was reduced significantly and 
rating of failure was given if the lesion was unchanged.  The Nd:YAG laser, TPDL, was used in 
coordination with ice cubes to increase the depth of the energy to 10mm. 24 
 Of the 165 patients, 65 superficial IH were gauged to be excellent while 107 superficial IH 
were gauged to be good.  Of the 54 subcutaneous and deep IH 64% did not show any change in 
appearance.  Overall the TPDL eliminated lesions in a remarkable manner with no scars noted. 24 
 In 2002, Batta, et al, published a one year randomized controlled study of pulsed dye (PDL) 
laser treatment on IH. The study included 121 infants ages 1-14 weeks with superficial hemangiomas.  
Infants were randomly assigned to PDL treatment (n=60) or observation (n=61). These infants were 
monitored for one year. Several assessments were made including residual signs, adverse reactions, 
and complications. 25 
 The PDL used was the Chromos 585 nm Venus flashlamp pulsed dye laser (SLS Biophile 
Dyfed, Wales UK) at a pulse duration of 0.45 ms, spot diameter of 3-5 mm and energy of 6.0-7.5 
J/cm2. Treatments were repeated every 4 weeks for a few seconds and without anesthesia.  The patients 
were followed up at ages 3, 6, 9, and 12 months. At these visits photographs and measurements were 
taken under consistent conditions.  Several measurements were taken including the height, size, and 
color of the hemangioma. 25 
 The objective of this study was to ascertain if the parents believed the hemangioma to be 
problematic. To omit bias, a panel of five independent parents, with 1 year old children themselves, 
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reviewed the photos of the studied children.  Of the panel of parents three of them had children with 
hemangiomas and two did not.  After viewing each photo the parent panel was asked their opinion on 
the question, “If your child had this hemangioma at the age of 1 year, how much of a problem would 
you consider it to be?” 25   These parents were unaware of which children received PDL or did not 
receive treatment, watchful-waiting. 25 
 Initially the surface areas of the hemangiomas did not differ significantly between the groups. 
However, the PDL children had a significantly reduced IH surface area after a few treatments. The 
median was 83mm2 for the observation and 38 mm2 for the laser treatment group, showed that the 
p=0.03 which is a significant improvement.   This change was greater than half the improvement of the 
non-treated group. 25 
 After the year both the treated and untreated children both had IH heights that were not 
significantly different to one another.  Redness was significantly reduced in the treatment group after 
one year. Yet the number of hemangiomas considered a problem at 1 year by the five parents did not 
significantly differ between the two groups either. 25   
 The study authored by Kono, et al, 2005, on uncomplicated hemangiomas, displayed the 
individual gains of the long-pulse dye laser (LPDL) in contrast to the traditional pulse dye laser 
(TPDL).   The study was randomized for 52 patients between the ages of 1-3 months of age.  Twenty-
six were assigned to TPDL, model Photogenica V by Cynosure, and 26 were assigned to LPDL with 
cryospray cooling, model V-beam of Candela.  The randomization of the patients was based on 
demography.26 
 The findings are noted in the research as minimal residual signs after one year of age.  Children 
who were treated with the TPDL had a greater residual sign by 11% when compared to the LPDL. 
When hypopigmentation was evaluated the TPDL had a higher finding by 19% compared to the LPDL.  
When treatment was started, in the proliferation phase, the LPDL treatment reduced the time of 
growing by 71 days compared to the TPDL.  26 
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 In 2006 a study by Sang-Hyuk, et al, was published on the effectiveness of 595 nm pulsed dye 
lasers on dark skinned patients with hemangiomas. The study included thirty-seven patients with 
hemangiomas. There were 28 females and 9 males, equating to a 3.1:1.0 ratio. All patients had 
Fitzpatrick skin phototypes of III to V. The variable-pulse 595 nm PDL, V-beam, manufactured by 
Candela Corportion, Wayland, WA, were used. This long-pulsed dye laser was equipped with a built-
in cooling spray that activates before each pulse for 30ms. Customized pulse duration (1.5-10 ms), 
energy 4.0-15.0J/cm2 and spot size (7 or 10mm) occurred depending on the individuals lesions. 27 
 To assess the results preoperative and postoperative photographs were taken by a digital 
camera (DSC-F707, Sony, Japan). It was stated that a thorough means of photographic quality and 
consistency was used. Two independent examiners evaluated the photographs. The categorized clinical 
response scores included: 0 (poor) 25% or less improvement; 1 (fair), 26-50% improvement; 2 (good), 
51-75% improvement, and 3 (excellent), 76% or more improvement. 27 (see graph 1)  
 The patients received an average of 6 treatment sessions. The average clinical response was 
1.68. The clinical response for the females was 1.71 and the males were 1.56. The clinical response 
scores for superficial hemangioma was 1.98 and deep was 1.08. 27  
 Stier, et al, 2007, authored laser treatment with TPDL neodymium:yttrium-aluminum-garnet 
(Nd:YAG). The laser was developed to treat vascular tumors without creating a scar.   The study 
included that avoiding thermal damage to the surrounding tissue is of great importance.  The thermal 
relaxation time would need to be great enough that the surrounding tissue was not affected by the 
coagulation of the IH tissue. The TPDL exposure time of the surrounding tissue is believed to be 
responsible for the scar tissue that unfortunately was developing with treatment.  20 
 Stier, et al, continues to describe cooling systems that would be able to decrease the damage to 
surrounding tissue containing the targeted IH.  Three cooling systems were developed.  Precooling is 
where the surrounding tissue is cooled just prior to the laser therapy.  Parallel cooling cools the skin 
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during the treatment where post-cooling reduces erythema and pain.  These are supported by the 
cryogen spray cooling. 20 
 The traditional pulse dye laser does not use cooling elements on the tissue.  This cooling 
system was included to reduce scarring of the surrounding tissue.  The time of exposure, per blast of 
the laser is one millisecond followed by 1-10 millisecond thermal relaxation time (TRT).  The TRT 
decreases the risk of heat conduction to the surrounding tissue. 20 
 The study explains how laser treatment is controversial because of the range of possible 
outcomes.20  Included in the study was the Journal of the American Academy of Dermatology 
recommendations for the treatment of IH under the following conditions: 1) function threatening 
including life threatening, 2) locations that are likely to create a scar (glabellar area, nose, lip, ear), 3) 
large facial IH, 4) smaller exposed areas of the hands and face, 5) ulcerated IH, and 6) pedunculated IH 
that could leave fibrous tissue after involution.28  Treatment, of some types, after 5 years of age is 
recommended to reduce the patient’s peers from damaging the child’s self awareness through teasing.28 
 If treatment is selected or indicated TPDL is best utilized on deep IH.  Stier continues to point 
out that the TPDL’s where better suited for the treatment of port wine stains no IH.  The vessels in IH 
are much closer to the surface of tissue making treatment with the TPDL more challenging.  When 
ulcerated IH are being treated TPDL use is more acceptable because the nature of the ulceration or 
infection could cause scarring alone. 20 
 This study suggested that the newer, long-pulse dye laser (LPDL) is more effective on deeper 
IH but there still is a risk of scarring.  The clinical recommendations made reflected that the laser 
systems addressing IH are not accurate enough to influence pediatric dermatologist to choose laser 
therapy over watchful waiting. 20 
Discussion       
 In 1995, Levine, et al, the PDL treatment study for hemangiomas showed some promising 
outcomes but the lower number of patients studied was not able to give a well rounded conclusion.  
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This study stated that no scarring occurred.  When compared to the other laser treatment studies they 
all had some form of complications including scarring.  The absence of no scarring must not have 
developed at the completion of the study.  This article did not give enough specific information to draw 
a conclusion but the background on the time period was valuable to support the more recent studies.  
The information was not able to show that watchful waiting was less productive in tumor resolution.23 
 The 2000 study evaluated pre and post treatment photos and where treatment was determined to 
be ineffective on deep hemangiomas.  Unfortunately, this finding contradicts the goal of the laser 
therapy, deeper penetration.  No improvement with or without treatment in some of the cases reduces 
the ability to discover a cause and effect ratio.24  There were significant changes in the tumor tissue on 
the superficial hemangiomas after the laser treatment. This shows that treat does reduce some of the 
symptoms of superficial IH. 24  
 The 2002 study was extremely thorough in recruiting patients. In one year 6000 mothers were 
educated on the appearance of hemangiomas. In fact the principal investigator personally checked 
2000 babies in that year to help identify early hemangiomas. This enabled them to have such definitive 
cohort. All patients were observed in the initial stages of a hemangioma and its growth for the first 
year. The JADAD score for this study was a 5 indicated this study’s quality. 25  
 In 2005 a new version of the laser treatment with cooling systems improved the outcome of the 
tissue.  This finding was relevant because the proponents for watchful waiting focus on the scar that 
develops after treatment.  With the cooling system the surrounding tissue is less affected by the heat of 
the laser therefore reducing scarring and causing IH reductions. 26 
 When examining the traditional pulse dye laser outcomes, 2007, it becomes increasingly 
obvious that the data is reflecting significant changes in the hemangioma that theoretically would not 
have occurred without any intervention.    This finding is comforting considering the patient is 
experiencing mild to moderate discomfort with the treatments. 27 
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Limitations of Study 
 The limitations of the study are hindered by the scale of patient who had been monitored during 
laser treatments on IH.  Many of the studies that were reviewed focused on the outcome of a certain 
number of patients that received treatment but the outcomes with laser therapy were generally a 
smaller tumor and reduced redness after the treatment.  Subjective judgment by the parent is the true 
gauge of treatment outcome.  The study that compared the laser therapy to non-treated patients 
revealed results that were better in tumor resolution measurement wise but the parental observers did 
not agree with the resolution done by photo grading.  This means that with a year of monthly laser 
treatments the subjective grading of the laser treated tumors versus the non-treated tumors was equal, 
in the parent’s opinion.  Some of the other articles pointed out that the risk of complications in pulse 
dye laser therapy were close to the benefits gained by the treatment.  These findings displayed a 
clinical benefit from the pulse dye laser but the outcome was not as valuable to the parent.  One 
limitation of the study was the location of the treated IH prior to the parent grading.  It would be 
acceptable for a treated IH in the middle of the face to get an unacceptable grade while an IH on the 
back of the ear to receive an acceptable grade.  Improvement of a tumors appearance seems to be 
graded more severely than the scientific method of measuring and comparing before and after color 
tones.  
Conclusion                                  
 Treatment decisions should be made by a specialist with the parent’s informed consent.  Doing 
no treatment is a valid option as well.  The severity of the hemangioma is the most influential fact 
when choosing a treatment.  The literature is relatively new, yet no real developments in total laser 
treatment are taking the lead in popularity.   
 A diagnosis through computer topography is generally unacceptable because of the radiation 
exposure associated with the imaging.  This imaging seems to be the point at which diagnosis and 
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treatment are linked, but few clinicians would expose an infant to radiation in order to identify a 
benign tumor which could improve with watchful waiting.   
 In reference to the laser treatment that would carry the least amount of risk with the greatest 
benefit the Long-pulsed laser with a cryocooling system is at the forefront of technology today.  
Considering some dermatologist would prefer to wait-and-see verses start aggressive laser therapy 
really limits the aspect of further large numbered studies.  As lasers are used in other medical 
capacities and it can only be assumed that a laser therapy designed for hemangioma resolution will be 
engineered.   
 The research on this subject did show a treatment benefit to laser therapy but there continues to 
be an associated risk of complications that the family of the patient would probably like to avoid.  
Until these complications are reduced laser therapy will continue to be a distant choice for treatment 
behind medication treatments or no treatment.  
 Collectively these studies showed that some form of benefit occurred after laser therapy but the 
risk to benefit ratio was not significantly high enough to grossly recommend laser therapy as an 
alternative to watchful waiting.  Watchful waiting is the standard at this time but if the family is 
persistently seeking a reduction in the infantile hemangiomas laser therapy is an option. 
 Overall, case by case options are the most accurate way to approach the treatment for the most 
common benign tumor, the infantile hemangioma. 
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Tables and Graphs 
Table 1: Outcomes of the Randomized controlled study of early pulsed dye laser treatment of 
uncomplicated childhood hemangiomas. 25  
Outcome PDL (n=60) Observation (n=61) P 
Height (mm)     
      0 33 31 0.61 
      1-2 12 11  
      3-5 6 11  
      6-10 5 6  
      >10 3 2  
Surface area (median, range) 113 (0-1500) 146 (0-2406) 0.21 
Redness    
      None 19 4  
      Mild 16 23  
      Moderate 20 18  
      Pronounced 5 16  
Average hemangioma problem grading of five independent parents 
         Not at all 42 40 0.82 
         A bit 8 10  
         Quite a bit 5 9  
         A lot 1 1  
         A big problem 4 1  
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Table 2: Results of Reviewed Articles 
JADAD Score Study Published Study Type Sample Size Comparison Results 
2 Adverse effects 
associated with the 
577 and 585-
nanometer pulsed 
dye laser in the 
treatment of 
cutaneous vascular 
lesions: A study of 
500 patient  
1995 Case study 500 Outcome of the 
hemangioma 
Pulse Dye Laser is 
safe in the 
treatment of 
vascular lesions 
2 Flashlamp-Pumped 
Pulsed Dye Laser for 
Hemangiomas in 
Infancy 
2000 Nonrandomized 
control trial 
165 Superficial and 
mixed hemangiomas 
and no treatment 
34% had excellent 
results and 52% 
had good results 
5 Randomised 
controlled study of 
early pulsed dye laser 
treatment of 
uncomplicated 
childhood 
haemangiomas: 
results of a 1-year 
analysis 
2002 Randomized 
controlled study 
121 Pulse dye lasers 
compared to wait-
and-see policy 
No significant 
benefit to Pulse 
Dye Laser 
4 Comparison Study of 
Traditional Pulsed 
Dye Laser Versus a 
Long-Pulsed Dye 
Laser in the 
treatment of Early 
Childhood 
Hemangiomas 
2005 Randomized 
controlled study 
52 Pulse dye laser 
compared to long-
pulse dye laser 
Long-pulse dye 
laser had more 
patient with an 
excellent rating and 
less than half the 
complications 
3 Treatment of 
Vascular Skin 
Lesions with the 
Variable Pulse 
595nm Pulsed Dye 
Laser 
2006 Case study of the 
type of vascular 
formations. 
37 Pulse Dye Laser 
treatment outcomes 
32% had excellent 
ratings and 22% 
had good ratings. 
2 Laser treatment of 
pediatric vascular 
lesions: Port wine 
stain and 
hemangiomas 
2008 Case Study Undetermined Pulse dye laser risk 
to benefit reflection 
Currently there are 
no adequeate laser 
systems for 
hemangioma 
treatment 
 
Table 3: PICO 
Population: Patients with facial or neck hemangiomas. 
Intervention: Laser therapy.   
Comparison: No treatment for infantile hemangiomas. 
Outcome: Involution of the tumor and resolution of the tissue. 
 
 
 
 24 
References 
1. Schlosser KA. Infantile hemangioma: How to treat this benign neoplasm of childhood. 
JAAPA.2009;22:46-49. 
2. Edgerton MT. Steroids and surgery in the management of cutaneous angiomas. In Neoplasms of the 
Skin and Malignant Melanoma. Chicago: Year Book Medical Publishers, 1976. 
3. Mulliken JB, Young AE. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia: 
Saunders, 1988. 
4. Enjolras O. Classification and management of the various superficial anomalies: Hemangiomas and 
vascular malformations. J Dermatol. 1997;24:701-706. 
5. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A 
classification based on endothelial characteristics. Plastic Reconstruction Surgery. 1982;69:412-415. 
6. Bowers RE, Graham EA, Tomlinson KM. The natural history of the strawberry nevus. Arch 
Dermatol.1960;82: 667-672. 
7. Cheung DS, Warman WL, Mulliken JB. Hemangiomain twins. Ann Plast Surg.1997; 38: 269-273. 
8. Sarkar M, Mulliken JB, Kozakewich HP, Robertson RL, Burrows PE. Thrombocytopenic 
coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma 
and not with common infantile hemangioma. Plast Reconst Surg. 1997;100:1377-1383. 
9. Boon LM, Enjolras O, and Mulliken JB. Congenital hemangioma: Evidence of accelerated 
involution. J Pedia. 1996;128:329-332. 
10. Zukerberg LR, Nickoloff, BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and 
childhood: An aggressive neoplasm associated with Kasabach-Merritt syndrome and 
lymphangiomatosis.  J Surg Pathol. 1993;17: 321-328. 
11. Walter JW, Blei F, Anderson JL, Orlow SJ, Speer M C, Marchuk DA. Genetic mapping of anovel 
familial form of infantile hemangioma. Am J Med Genet. 1999;82: 77-81. 
12. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N. Engl. J. Med. 1999;341:173-178. 
13. T.Colombani, and R. P. Foglia (Eds.), Surgery of Infants and Children: Scientific Principles and 
Practice. Philadelphia: Lippincott-Raven Publishers, 1997. 
14. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol. 
1993;10:311-318. 
15. Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular 
birthmarks. Dermatol Clin. 1998;16: 455-500. 
16. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: Clinical application of a new 
classification. J Pedia Surg. 1983;18: 894-899. 
17. Frieden IJ, Reese V, Cohen D. PHACE syndrome: The association of posterior fossa brain 
malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye 
abnormalities. Arch Dermatol. 1996;132: 307-311. 
18. Gorlin RJ, Kantaputra P, Aughton DJ, and Mulliken JB. Marked female predilection in some 
syndromes associated with facial hemangiomas. Am J Med Genet. 52: 130, 1994. 
19. Leng T, Wang X, Huo R, Cheng Z, Feng Y. The value of three-dimensional computed tomographic 
angiography in the diagnosis and treatment of vascular Lesions. Plas Reconstr Surg. 2008;122:1417-
1424. 
20. Stier MF, Glick SA, Hirsch RJ. Laser Treatment of pediatric vascular lesions: port wine stains and 
hemangiomas. Am Acad Dermatol. 2008;58:261-285. 
21. Bulent S, Shah Anil R. Chapter 5. Lasers in Head & Neck Surgery". In: Lalwani AK: CURRENT 
Diagnosis & Treatment in Otolaryngology—Head & Neck Surgery, 2nd Edition: 
http://www.accessmedicine.com/content.aspx?aID=2824044. Accessed June 23, 2009. 
22. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas 
implications for management. Pedia. 2008;122:360-367.  
 25 
23. Levine VJ, Germonemus RG. Adverse effects associated with the 577- and 585- nanometer pulsed 
laser in the treatment of cutaneous vascular lesions: a study of 5000 patients.  Am Acad  Dermatol. 
1995;32:613-617. 
24. Poetke M, Philipp C, Berlien HP. Flashlamp-pumped dye laser for hemangiomas in infancy. Am 
Med Ass. 2000;136:628-632.  
25. Batta K, Goodyear HM, Moss C, Williams HC, Hiller L. Waters R. Randomized controlled study 
of early pulsed dye laser treatment of uncomplicated childhood haemagniomas: results of a 1 year 
analysis. The Lancet. 2002;360:521-527. 
26. Kono T, Sakurai H, Groff WF, Chan H, et. al. Comparison study of a traditional pulsed dye laser 
versus a long-pulsed dye laser in the treatment of early childhood hemangiomas. Lasers Surg and Med. 
2005;38:112-115. 
27. Woo SH, Ahn HH, Kim SN, Kye YC. Treatment ofVascular skin lesions with the variable pulse 
595 nm pulsed dye laser. Am Soc Dermatol Surg. 2006;32:41-48.  
28. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for 
hemangiomas of infancy. J Am Acad Dermatol. 1997;37:631-637. 
 
